elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26742107-6ECA111A-66C0-43ED-A394-626BE8055D3B
Q26742107-6ECA111A-66C0-43ED-A394-626BE8055D3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26742107-6ECA111A-66C0-43ED-A394-626BE8055D3B
Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy
P2860
Q26742107-6ECA111A-66C0-43ED-A394-626BE8055D3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26742107-6ECA111A-66C0-43ED-A394-626BE8055D3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e35de25e373ec8676ecb86837a1b1ea6a9472c4
P2860
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.